Claritev

CTEV on NYSE. Claritev sells healthcare cost data and analytics to healthcare organizations. Market value $418m.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Look carefully before going further

Read the warning sign in its own filings

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
-4.4%low

For every $100 of what the whole company costs, it produced $-4.39 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
154.8×full

You pay 154.8 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
0.5%five-year median

Each dollar kept in the business earns 1 cents a year. Above 10 is good.

Quality score: 18 of 100. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.

$24.09 a share, 109% above its 1-year low

Over the past year the price has ranged from $11.50 to $73.68.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

0.3
0.3
0.1
-0.0
-0.0
-0.0
2021202220232024202512 monthsto Jun '26

Spare cash swings from quarter to quarter here: a shortfall of $18 million in the past 12 months, a shortfall of $12 million in the year to December 2025.

Revenue
$1.1bn$1.1bn$962m$931m$965m
Operating margin
34.5%-33.6%16.8%-149.4%3.0%
Debt to equity
2.122.692.6954.34n/a
Shares outstanding
0.64bn0.65bn0.02bn0.02bn0.02bn

Health checks

  • Free cash flow positive3 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)4 of 9
  • Profit backed by cash (accruals)Yes
  • DebtUnknown
  • Revenue growth, five yearsSlow, 0.6% a year
  • Buying back its own sharesYes, 97% fewer since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $257 million last quarter, up 7% on a year ago.
  • A loss of $59 million, compared with a loss of $63 million a year ago.
  • It keeps 3 cents of each $1 of sales as operating profit, after losing 38 cents a year earlier.
  • Over the past 12 months it spent $18 million more cash than it brought in, compared with $55 million a year earlier.
  • 3% more shares than a year ago. Each share owns a bit less of the company.
  • Debt is $4.6 billion more than cash, up from $4.5 billion a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$230m
December 2024$232m
March 2025$231m
June 2025$242m
September 2025$246m
December 2025$247m
March 2026$245m
June 2026$257m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024-$391m
December 2024-$138m
March 2025-$71m
June 2025-$63m
September 2025-$70m
December 2025-$81m
March 2026-$74m
June 2026-$59m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
26 February 2026
Next quarterly (estimated, 10-Q)
6 November 2026

Who owns it

None of the long-term investors we follow own it. 102 funds in all.

Jun '25
Dec '25
Jun '26

Sold out this quarter

Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

  • Hellman & Friedman Investors VIII, L.P.
    Passive investor
    at least 23.5%
    (filed with 10 related holders)
    Since 12 November 2025
    What they said

    Item 4 of the Schedule 13D is hereby amended and restated as follows: The Reporting Persons acquired the securities reported herein for investment purposes and intend to continue to review their investments in Claritev Corporation (the "Issuer") on an ongoing basis. Except as…

    Read the filing
  • ASOF Investment Management LLC
    Passive investor
    at least 11.5%+6.0 pts
    (filed with 8 related holders)
    Since 5 February 2025
  • Arini Capital Management Limited
    Passive investor
    at least 9.1%+1.5 pts
    (filed with 5 related holders)
    Since 31 December 2025
  • at least 4.8%
    (filed with 8 related holders)
    Since 14 January 2025
  • GIC Private Limited
    Passive investor
    Sold down below 5%
    Since 22 September 2026

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 7 insiders bought $2m of shares on the open market. 3 sold $919,345, $276,075 of it under preset trading plans.

  • Garis Douglas Michael
    EVP&CFO
    Sold
    under a preset trading plan
    Date
    21 September 2026
    Shares
    9,025
    Price
    $30.59
    Value
    $276,075
  • Dalton Travis
    Pres., CEO & Executive Chair, Director
    Bought
    Date
    28 August 2026
    Shares
    1,950
    Price
    $38.48
    Value
    $75,040
  • Dalton Travis
    Pres., CEO & Executive Chair, Director
    Bought
    Date
    27 August 2026
    Shares
    4,500
    Price
    $38.81
    Value
    $174,623
  • Misencik Tiffani
    SVP, Chief Growth Officer
    Sold
    Date
    14 August 2026
    Shares
    8,850
    Price
    $40.07
    Value
    $354,593
  • Mintz William B.
    SVP, Chief Strategy Officer
    Sold
    Date
    10 August 2026
    Shares
    8,431
    Price
    $34.24
    Value
    $288,677
  • Carol Nutter
    SVP, Chief People Officer
    Bought
    Date
    9 June 2026
    Shares
    875
    Price
    $28.41
    Value
    $24,859
  • Prince John Michael
    Director
    Bought
    Date
    19 May 2026
    Shares
    10,000
    Price
    $16.00
    Value
    $160,000
  • Dalton Travis
    Pres., CEO & Executive Chair, Director
    Bought
    Date
    18 May 2026
    Shares
    20,920
    Price
    $12.36
    Value
    $258,638
  • Kim Michael
    EVP, Chief Digital Officer
    Bought
    Date
    18 May 2026
    Shares
    3,000
    Price
    $16.65
    Value
    $49,950
  • Garis Douglas Michael
    EVP&CFO
    Bought
    Date
    16 March 2026
    Shares
    1,300
    Price
    $17.69
    Value
    $22,997

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in Claritev’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 26 Feb 2026, plus the 10-Q filed 7 Aug 2026 and 8 later 8-Ks.

  • Weak checks on its own accounts

    Serious

    The company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.

    “Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of June 30, 2026, as a result of the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.”
    Show the full paragraph
    Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial and accounting officer, the Company conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of June 30, 2026, as a result of the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

    From the 10-Q filed 7 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing

  • One big customer

    Worth knowing

    One customer brings in a big share of sales: 29.2% last year. Losing that customer would hurt.

    “Two clients individually accounted for 29.2% and 10.4% of total revenues for the year ended December 31, 2025, and two clients individually accounted for 27.7% and 15.9% of total revenues for the year ended December 31, 2024.”

    From the 10-K filed 26 February 2026, Item 1. Business. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • Sales have barely grown: 0.6% a year.
  • It owes more than it owns on paper (negative equity). Often that's from borrowing to buy back shares.
  • It isn't cheap on profits: 154.8× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.